RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia. (2020)

First Author: Chin PS
Attributed to:  Finding therapeutic targets in FLT3-ITD AML using a systems biology approach funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2020.10.005

PubMed Identifier: 33152396

Publication URI: http://europepmc.org/abstract/MED/33152396

Type: Journal Article/Review

Volume: 92

Parent Publication: Experimental hematology

ISSN: 0301-472X